北京11选5开奖直播:Croda Acquires Research Enterprise Enza Biotech

北京快三助手 www.nsg5.cn Croda International Plc (‘Croda’), who make, create and sell innovative and sustainable speciality chemicals has today announced its acquisition of Enza Biotech AB, a research enterprise established as a spin-out company from Lund University in Sweden.

 

Enza Biotech was founded in 2012 by researchers at Lund University with the aim to develop the next generation of renewable surfactants using carbohydrate-based chemistry. Through this acquisition, Enza Biotech’s patented technology will enhance Croda’s well-established natural and renewable product portfolio to offer their customers, particularly in the Personal Care, Crop Care and Health Care markets, the sustainable ingredients they are looking for to satisfy the demands of consumers.

 

Croda will also gain the expertise of Enza co-founders Maria Andersson and Stefan Ulvenlund, and their team, as they become full time employees to lead the commercialisation of their work using Croda’s technical and formulation expertise, global operational footprint and sales force and track record at bringing new technologies to market.

 

This acquisition demonstrates Croda’s commitment to delivering sustainable solutions without compromising on product performance as this novel range of surfactants has been proven to offer differentiated performance benefits across many applications, such as emulsification, wetting and dispersion.

 

Steve Foots, Chief Executive of Croda, said: “Enza Biotech offers a fantastic opportunity for us to fill an identified technology gap in the surfactants market using natural and renewable raw materials. It is a great fit as sustainability underpins our growth strategy and is an area that already sets us apart in the eyes of our customers.”

 

Maria Andersson, Chief Executive Officer and co-founder of Enza Biotech said: “Croda is the perfect fit for our technology due to their commitment to investing in innovative and sustainable solutions. With their proven track record in bringing new technologies to market and strong customer relationships, we are confident Enza Biotech will have a bright future. We look forward to working with the Croda team and the new opportunities that will bring.”

For more information, please use our online contact form .
--- ENDS ---
About Croda Health Care
Croda is a global leader in speciality chemicals sold to a wide range of industries. The Croda Health Care division provides high quality ingredients for nutritional and pharmaceutical markets, with particular expertise in speciality lipids. High investment in GMP, API technologies and R&D ensures Croda is well positioned for the continual delivery of exceptional ingredients.
//www.nsg5.cn/healthcare
  • 青海100个最美观景拍摄点 2019-02-15
  • 壮阔东方潮 奋进新时代——庆祝改革开放40年——山西黄河新闻网 2019-02-15
  • 湖北省纪委重申“十个严禁”确保廉洁过端午 2019-02-14
  • 香江直通车之专访香港义工联盟常务副主席马浩文 2019-02-11
  • 候选企业:拜耳医药保健有限公司 2019-02-11
  • 端午节小长假海河游船加开班次 2019-02-01
  • 进去是旧衣 出来成新料 2019-01-27
  • 40载情定广彩 终练就“国大师” 2019-01-27
  • FONT color=red习近平:自主创新推进网络强国建设FONT 2019-01-20
  • 六岁孩子回家偶遇交警老爸 雨中默默陪爸爸执勤 2019-01-20
  • 郭万超 马萱:全球视野下的中国文化产业价值链 2019-01-19
  • 窃贼落网瞒余罪 出狱当天又被抓 2019-01-19
  • 姜平的专栏作者中国国家地理网 2019-01-09
  • 武汉拟扩大公租房轮候期间应保尽保范围 2019-01-09
  • 扎达土林——大自然的杰作文章中国国家地理网 2018-12-19
  • 311| 129| 297| 778| 527| 198| 923| 646| 994| 856|